ATTANA AB |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.081 SEK | +12.50% |
|
+8.00% | -18.18% |
| Apr. 30 | BioInvent Announces Evaluating Attana Technology | CI |
| Apr. 25 | Attana AB Enters Third Year of A Five-Year Service and Support Contract with A Leading Health Institute in the US | CI |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 49.92 | 143 | 334.1 | 159.1 | 41.6 | 26.99 |
| Enterprise Value (EV) 1 | 51.46 | 142.5 | 300.5 | 148.3 | 44.85 | 30.18 |
| P/E ratio | -8.34 x | -14.6 x | -31.5 x | -9.33 x | -2.84 x | -1.96 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 9.66 x | 18.4 x | 44.6 x | 18.8 x | 3.17 x | 3.96 x |
| EV / Revenue | 9.96 x | 18.3 x | 40.1 x | 17.5 x | 3.42 x | 4.43 x |
| EV / EBITDA | -9.87 x | -22.2 x | -32.1 x | -9.44 x | -3.41 x | -2.6 x |
| EV / FCF | -24 x | -14.6 x | -45 x | -8.95 x | -5.26 x | -2.75 x |
| FCF Yield | -4.17% | -6.84% | -2.22% | -11.2% | -19% | -36.4% |
| Price to Book | 6.78 x | 9.8 x | 7.01 x | 5.08 x | 2.56 x | 1.46 x |
| Nbr of stocks (in thousands) | 121,764 | 170,469 | 170,469 | 209,067 | 209,067 | 272,658 |
| Reference price 2 | 0.4100 | 0.8390 | 1.960 | 0.7610 | 0.1990 | 0.0990 |
| Announcement Date | 3/22/19 | 4/24/20 | 5/7/21 | 5/4/23 | 5/4/23 | 4/18/24 |
1SEK in Million2SEK
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 5.166 | 7.792 | 7.49 | 8.477 | 13.11 | 6.82 |
| EBITDA 1 | -5.216 | -6.423 | -9.353 | -15.71 | -13.17 | -11.62 |
| EBIT 1 | -5.828 | -6.994 | -9.918 | -16.59 | -14.17 | -12.36 |
| Operating Margin | -112.82% | -89.76% | -132.42% | -195.74% | -108.14% | -181.29% |
| Earnings before Tax (EBT) 1 | -5.986 | -7.383 | -10.62 | -16.8 | -14.64 | -13.79 |
| Net income 1 | -5.986 | -7.383 | -10.62 | -16.8 | -14.64 | -13.79 |
| Net margin | -115.88% | -94.76% | -141.81% | -198.2% | -111.67% | -202.17% |
| EPS 2 | -0.0492 | -0.0576 | -0.0623 | -0.0815 | -0.0700 | -0.0506 |
| Free Cash Flow 1 | -2.147 | -9.737 | -6.678 | -16.58 | -8.524 | -10.99 |
| FCF margin | -41.57% | -124.97% | -89.16% | -195.53% | -65.03% | -161.14% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 3/22/19 | 4/24/20 | 5/7/21 | 5/4/23 | 5/4/23 | 4/18/24 |
1SEK in Million2SEK
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 1.54 | - | - | - | 3.24 | 3.18 |
| Net Cash position 1 | - | 0.57 | 33.6 | 10.8 | - | - |
| Leverage (Debt/EBITDA) | -0.2949 x | - | - | - | -0.2463 x | -0.2739 x |
| Free Cash Flow 1 | -2.15 | -9.74 | -6.68 | -16.6 | -8.52 | -11 |
| ROE (net income / shareholders' equity) | -57.8% | -67.3% | -34.1% | -42.8% | -62.1% | -79.5% |
| ROA (Net income/ Total Assets) | -20.5% | -24.5% | -15.5% | -21.5% | -26.9% | -24.8% |
| Assets 1 | 29.14 | 30.15 | 68.38 | 78.16 | 54.46 | 55.5 |
| Book Value Per Share 2 | 0.0600 | 0.0900 | 0.2800 | 0.1500 | 0.0800 | 0.0700 |
| Cash Flow per Share 2 | 0.0100 | 0.0200 | 0.2200 | 0.0600 | 0 | 0 |
| Capex 1 | 0.11 | - | - | 0.66 | 0.44 | 0.08 |
| Capex / Sales | 2.21% | - | - | 7.82% | 3.35% | 1.1% |
| Announcement Date | 3/22/19 | 4/24/20 | 5/7/21 | 5/4/23 | 5/4/23 | 4/18/24 |
1SEK in Million2SEK
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -18.18% | 2.56M | |
| -29.76% | 924M | |
| -19.12% | 130M | |
| -7.98% | 68.37M | |
| +6.78% | 60.11M | |
| +1.80% | 52.22M |
- Stock Market
- Equities
- ATANA Stock
- Financials Attana AB
